INDEPENDENT MEDICAL EDUCATION
THURSDAY, September 7, 2023 – 16:30 - 17:30 - Room C01
IME – Ocular Surface
Moderators: Leonardi A, Bodaghi B
Session supported by
| 16:30 | Management of ocular allergy |
| Leonardi A | |
| 16:39 | Management of dry eye disease and its complications |
| Baudouin Ch | |
| 16:48 | Current management of mucous membrane pemphigoid |
| Doan S | |
| 16:57 | Management of meibomian gland dysfunction |
| Messmer E | |
| 17:06 | Autoimmune keratitis |
| Pleyer U | |
| 17:15 | Management of scleritis |
| Pavesio C | |
| 17:24 | Discussion |
| 17:30 | End of Session |
Session supported by
Saturday, September 9, 2023 – 15:10 - 16:10 - Room C01
IME – AMD and Non-Uveitic Choroidal Neovascularization - The Role of Inflammation in Age-Related Macular Degeneration Moderators: Crincoli E, Nguyen QD
Session supported by
| 15:10 | Microvascular Changes in Treatment Naïve Quiescent Macular Neovascularization Complicated by Exudation |
| Crincoli E | |
| 15:18 | Dazdotuftide as a Feasible, Multi-target Anti-inflammatory Compound for Age-related Macular Degeneration, Diabetic Retinopathy, and Diabetic Macular Edema |
| Chowers I | |
| 15:26 | Perifoveal Vascular Anomalous Complex and the Spectrum of Degenerative Microvascular Macular Diseases |
| Crincoli E | |
| 15:34 | Inflammation in AMD Pathogenisis: Geographic Atrophy and Beyond |
| Fung N | |
| 15:42 | Inflammation and AMD: New Therapeutic Perspectives |
| Le HM | |
| 15:50 | Association of Oral Montelukast with Reduced Risk of Neovascular Age-related Macular degeneration |
| Matsumiya W | |
| 15:58 | Panel Questions |
| with Quan Dong Nguyen, Emanuele Crincoli and All Faculty Members | |
| 16:10 | End of Session |
Session supported by